Relation between breast cancer related gene BRCA1 and the sensitivity to docetaxel chemotherapy
10.3760/cma.j.issn.1674-6090.2014.05.004
- VernacularTitle:乳腺癌相关基因BRCA1与多西紫杉醇化疗敏感性研究
- Author:
Yong ZHANG
;
Yue YANG
;
Junsong YE
;
Lei ZHANG
- Publication Type:Journal Article
- Keywords:
Breast cancer;
BRCA1 gene;
Docetaxel;
Chemotherapy sensitivity
- From:
Journal of Endocrine Surgery
2014;8(5):362-364
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship between the expression of BRCA1 in breast cancer tissues and the sensitivity to docetaxel chemotherapy.Methods The expression of BRCA1 was detected by immunohistochemical method and the new adjuvant chemotherapy containing docetaxel chemotherapy regimen (TEC)was given.The relationship between BRCA1 expression and efficacy of neoadjuvant chemotherapy with docetaxel was studied.Results The rate of complete response,partial response,stable disease and progress disease was 22.6％,71.7％,5.7％,and 0％ respectively in breast cancer patients with positive BRCA1 expression and 11.8％,58.9％,27.4％,and 2.0％ in breast cancer patients with negative BRCA1 expression.The difference between the 2 groups had statistical significance.Conclusion BRCA1 expression has a positive relationship with sensitivity to chemotherapy regimen containing docetaxel chemotherapy regimens (TEC),and can be used as a good marker for predicting efficacy of chemotherapy and screening agents.
